January 2013

Article
Updated
Article Inclusion of TB in National Insurance Programs

In 2011-2012, the USAID TB CARE II project implemented by University Research Co., (URC) undertook a series of case studies to examine the extent to which TB has been integrated into National Health Insurance (NHI) programs in several high burden TB countries and to analyze the impact of NHI on achievement of National TB Control objectives. Assessments were carried out in four countries: Thailand, Peru, Phillippines, and India.

12 Aug 2013 17:58
Article TB CARE II Introduces Field Guide for the Management of Multidrug-Resistant TB in Children

TB CARE II recently introduced a new field guide on the management of pediatric Multidrug-Resistant Tuberculosis (MDR-TB) at the Union World Conference.

18 Sep 2013 14:57
Article CDC-Lab Project Helps SANU Launch Medical Laboratory Science Programme

Begining in August 2012, Students at Southern African Nazarene University (SANU) in Manzini, Swaziland can now complete a Bachelor of Science in Medical Laboratory Science Programme (BSMLSP), a degree program developed by the university in partnership with the TB and HIV Laboratory Technical Assistance Project, implemented by University Research Co., LLC (URC) through support from the US Centers for Disease Control.

The BSMLS Programme is a certification program that includes courses in basic sciences, communication skills, computing for health sciences, anatomy and physiology, as well as religious studies. Twenty-nine students were enrolled in the first semester starting in August 2012, most of whom will be sponsored by the Government Scholarship Programme. SANU also launched a Pharmacy Assistant course this semester. 

At a launch ceremony held November 1, 2012, the Prime Minister of Swaziland offered the following words: "The courses represent a direct response to the priorities of His Majesty's Government and the outcome of extensive consultations between SANU and Government. The SANU University Senate gave approval for the two programmes to commence in August 2012 and we are grateful for the innovative spirit shown by SANU in introducing these highly relevant courses."

06 Jan 2013 12:44
Basic page
Updated
Basic page Welcome to TB CARE II

TB CARE II is a five-year project from the United States Agency for International Development designed to provide global leadership and assist National Tuberculosis Programs in high burden countries around the world to accelerate the implementation of programs for TB DOTS, TB/HIV and Programmatic Management of Drug Resistant TB (PMDT). Led by University Research Co., LLC (URC), the TB CARE II Project team is comprised of leading organizations involved in building TB service delivery systems worldwide, including Partners in Health, Jhpiego, Project HOPE, and many others. TB CARE II programs work with a wide segment of stakeholders, including policy planners, public sector providers, communities, and patients to scale up evidence-based interventions and improve outcomes in tuberculosis prevention and control.

03 Jan 2013 14:58
Basic page Project Team

The TB CARE II project team draws from the array of expertise available in the consortium. In addition to the lead project staff listed below, our team consists of global experts in the areas of TB DOTS, TB/HIV. MDR TB, health systems strengthening, laboratories and diagnostics, infection control, supply chain management, health information systems, and health workforce development.

03 Jan 2013 14:58
Basic page Health Systems Strengthening

TB CARE II supports health systems improvement through our country programs, emphasizing management capacity building, integration, and results-oriented process improvement.

09 Jan 2013 11:30
Basic page Malawi: Accelerating implementation of national TB priorities

TB continues to remain a major public health problem in Malawi. According to the WHO, there were an estimated 46,000 new cases of TB (all forms) in the year 2009. Currently an estimated 64% of TB patients are also co-infected with HIV.

03 Jan 2013 14:58
Basic page TB-HIV Treatment

TB CARE II works to link HIV and TB advocacy and to promote a unified response, and works with National TB and HIV/AIDS Programs to integrate planning and service delivery mechanisms to effectively tackle the dual epidemics.

09 Jan 2013 11:27
Basic page Bangladesh: Building systems to improve access to TB services

Bangladesh currently ranks sixth among the 22 highest burden TB countries in the world. Stronger health services are needed to combat the estimated 360,000 new TB cases emerging each year and prevent the more than 70,000 TB-related deaths among the country’s young and growing population.  Multi-drug resistant TB (MDR-TB) is also a growing threat for Bangladesh, with more than 9,800 cases in 2008, although the capacity to diagnose and treat MDR-TB remains limited.

03 Jan 2013 14:58
Basic page About TB CARE II
The USAID TB CARE II Project is a five-year cooperative agreement implemented by a wide consortium of health and development organizations and led by University Research Co., LCC (URC).  The USAID TB CARE II Project began in 2010 with the aim of complementing and building upon existing and planned projects in the Bureau for Global Health to provide global leadership and support to National TB Programs (NTPs) and other in-country partners. The project works closely with the Centers of Disease Control and Prevention (CDC) and other USG partners at the global level and in high burden TB countries.  
TB CARE II is designed to assist NTPs and other stakeholders to accelerate the implementation of TB DOTS, TB/HIV and Programmatic Management of Drug Resistant TB (PMDT) programs. TB CARE II programs work with a wide segment of stakeholders, including policy planners, public sector providers, communities, and patients to scale up evidence-based interventions and improve outcomes in tuberculosis prevention and control.
 
The objectives of TB CARE II are:
  • TB care and treatment (DOTS expansion and strengthening): TB CARE II partners assist national programs to provide universal and early case detection to surpass the 70% target and successfully treat over 85% of those cases.
  • Programmatic Management for Drug Resistant TB (PMDT): The project works to assist national programs to provide universal access to DST for suspected cases and treatment to all those with MDR TB cases.
  • TB/HIV care and treatment: Our team is assisting countries to increase early case detection, expand intensified case finding, enhance airborne infection control efforts and expand access to and integrate treatment of TB and HIV in co-infected individuals.
  • Health Systems Strengthening: TB CARE II seeks to fully contribute to health system strengthening as it relates to TB, particularly for improving political commitment, strengthening human resources, enhancing health information and surveillance systems, infection control, and engaging all care providers.
 
The URC-led TB CARE II consortium consists of a group of organizations bound by a common desire to reduce the impact of TB, especially in high burden TB and HIV settings. Our team members bring extensive expertise in strengthening TB services, including combating the spread of MDR TB, in countries around the world. The URC Consortium partners include field implementation partners such as Partners In Health, Jhpiego and Project HOPE. In addition, the TB CARE II consortium also includes technical partners who will contribute their specialized expertise, including BEA Enterprises, Inc. (BEA); the Canadian Lung Association (CLA); Clinical and Laboratory Standards Institute (CLSI); Dartmouth Medical School: The Section of Infectious Disease and International Health (IDIH/DMS); Euro Health Group (EHG); and the New Jersey Medical School Global Tuberculosis Institute (GTBI).  The TB CARE II programs also collaborate with the following organizations: BroadReach HealthCare (BRHC); Foundation for Innovative New Diagnostics (FIND); Medical Service Corporation International (MSCI; National Jewish Health (NJH); and Project Concern International (PCI).
 
TB background and resources
 
Some facts about tuberculosis:
  • Tuberculosis is an infectious disease caused by the bacterium M. tuberculosis.
  • Worldwide, roughly one in three people carry TB. Although the majority of people do not get sick with an active infection, new infections occur on a rate of about one per second. TB is easily spread through the air when people who have the disease cough.
  •  In 2008, there were an estimated 9.4 million new TB cases, and 1.8 million TB deaths. TB causes more deaths worldwide than any other curable infectious disease and disproportionately affects the poor and working-age segments of society.
  • There are 22 countries currently designated by the World Health Organization as high burden countries which require extra support to tackle TB. These countries are spread throughout Asia, Africa, Europe and Latin America and include India, China, Russia, South Africa, and Brazil, among others.
  • One of the main factors in the resurgence of TB is the expanding HIV epidemic. TB is the leading cause of death among people living with HIV/AIDS. It is easily spread among people whose immune systems are suppressed by the AIDS virus and in some countries up to 80% of TB patients also have HIV.
  • The basic regimen of TB drugs has not changed in over forty years. TB treatment is long and complicated, involving six months of daily medications which can have severe side effects.
  • The key TB treatment strategy currently is the DOTS approach, for Directly Observed Treatment, Short Course. In this strategy, a patient is observed by a nurse or community health worker daily when taking their TB medications. This method is endorsed by the World Health Organization and currently implemented in the majority of countries with high rates of TB.
  • In some areas of the world, one in four people with TB becomes ill with a form of the disease that can no longer be treated with standard drugs regimens. However, only an estimated 7% of all drug-resistant TB cases are diagnosed and only 60% of patients with drug resistant TB are cured.
For more information about TB, treatment approaches, and current global initiatives, please see the links below:
22 Oct 2013 15:46
Basic page DOTS Strengthening

Strengthing basic DOTS is at the heart of long-term effective TB control. DOTS represents the best strategy for coordinating TB services within the broader health system, mobilizing wide support at the operational level, reducing TB incidence, and preventing further drug resistance. As such, TB CARE II is committed to working with National TB Programs to expand and develop capabities to implement DOTS within the framwork of their national TB priorities. 

03 Jan 2013 14:58
Basic page What We Do
  • TB care and treatment (DOTS expansion and strengthening): assist national programs using field support to provide universal and early case detection to surpass the 70% target and successfully treat over 85% of those cases.
  • Programmatic Management for Drug Resistant TB (PMDT): assist national programs using field support to provide universal access to DST for suspected cases and treatment to all those with MDR TB cases.
03 Jan 2013 14:58
Basic page Who We Are: Project Team

The Project Team

The TB CARE II project team draws from the array of expertise available in the consortium. In addition to the lead project staff listed below, our team consists of global experts in the areas of TB DOTS, TB/HIV. MDR TB, health systems strengthening, laboratories and diagnostics, infection control, supply chain management, health information systems, and health workforce development.

03 Jan 2013 14:58
Basic page Who We Are: TB Background and Resources

TB background and resources

Some facts about tuberculosis:

03 Jan 2013 14:58
Basic page Country Programs

The USAID TB CARE II Project can assist country programs to scale up evidence-based interventions and improve outcomes in tuberculosis prevention and control in the USAID TB Priority countries. TB CARE II works with National TB Programs through both long term field programs and targeted short term assistance in specific TB program areas. Click on one of the countries below for more information about TB CARE II activities. For more information about how TB CARE II can provide assistance in your country, click here.

09 Jan 2013 11:12